Hypoxic Pulmonary Vasoconstriction and Gas Exchange During Exercise: METHODS

Patients
Eight male patients (x ± SEM, 62 ±1 year) with the standard clinical criteria of COPD and with previous functional confirmation of nonreversible chronic airflow limitation (FEV„ 1.15 ±0.12 L [36 ±3 percent predicted]) were selected from the outpatient clinic of our institution. None of them had clinical evidence of overt right heart failure. Type В COPD was present in five patients whereas the three remaining patients had predominantly type A COPD. Consent was obtained after the purposes and risks of the investigation were explained and understood by each patient. All were clinically stable (none had required hospitalization during the previous two months) and none had evidence of renal, liver, or intrinsic heart disease. None of them was receiving oxygen therapy at home. Pulmonary function test (PFT) evaluation included measurement of static and dynamic lung volumes (HF-47804A Pulmonary System Desk; Hewlett-Packard, Palo Alto, Calif), plethysmography functional residual capacity and airway resistance (Body test, E. Jaeger, WUrzburg, FRC), and single-breath carbon monoxide diffusing capacity (Deo) (Resparameter model A, PK Morgan Ltd, Chatham, UK). The Deo values were corrected for hemoglobin. Predicted values for PFT were from our own laboratory.










